Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Baudax Bio stock
Learn how to easily invest in Baudax Bio stock.
Baudax Bio Inc is a biotechnology business based in the US. Baudax Bio shares (BXRX) are listed on the NASDAQ and all prices are listed in US Dollars. Baudax Bio employs 57 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Baudax Bio
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – BXRX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Baudax Bio stock price (NASDAQ: BXRX)Use our graph to track the performance of BXRX stocks over time.
Baudax Bio shares at a glance
|Latest market close||$0.20|
|52-week range||$0.19 - $2.12|
|50-day moving average||$0.39|
|200-day moving average||$0.67|
|Wall St. target price||$1.83|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.05|
Buy Baudax Bio shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Baudax Bio stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Baudax Bio price performance over time
|1 week (2022-01-10)||-2.28%|
|1 month (2021-12-17)||-41.84%|
|3 months (2021-10-15)||-63.64%|
|6 months (2021-07-16)||-67.07%|
|1 year (2021-01-15)||-84.48%|
|2 years (2020-01-17)||-97.27%|
|3 years (2019-01-13)||N/A|
|5 years (2017-01-13)||N/A|
Baudax Bio financials
|Gross profit TTM||$-1,239,000|
|Return on assets TTM||-53.3%|
|Return on equity TTM||0%|
|Market capitalisation||$17.7 million|
TTM: trailing 12 months
Baudax Bio share dividends
We're not expecting Baudax Bio to pay a dividend over the next 12 months.
Baudax Bio share price volatility
Over the last 12 months, Baudax Bio's shares have ranged in value from as little as $0.1915 up to $2.12. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Baudax Bio's is 2.0031. This would suggest that Baudax Bio's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Baudax Bio overview
Baudax Bio, Inc. , a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with non-NSAID analgesics. Its products under development includes BX1000, an intermediate-acting neuromuscular blocking agent (NMBA) that is in phase I clinical trial; BX2000, an ultrashort-acting NMBA, which is in pre-clinical trial; and BX3000, an NMBA reversal agent, which is under pre-clinical trial, as well as Dex-IN, a proprietary intranasal formulation of dexmedetomidine, which is under phase II clinical trial. The company was incorporated in 2019 and is based in Malvern, Pennsylvania. .
Baudax Bio in the news
Supreme Court vaccine mandate ruling won't bar companies from demanding Covid shots for workers — Biden vows to advocate for that
Two of Sen. Kyrsten Sinema's former aides have lobbied for corporate giants looking to influence Joe Biden's agenda
Joe Manchin's former aides gain influential lobbying clients as their ex-boss battles Biden's agenda
Frequently asked questionsWhat percentage of Baudax Bio is owned by insiders or institutions?
Currently 0.986% of Baudax Bio shares are held by insiders and 11.387% by institutions. How many people work for Baudax Bio?
Latest data suggests 57 work at Baudax Bio. When does the fiscal year end for Baudax Bio?
Baudax Bio's fiscal year ends in December. Where is Baudax Bio based?
Baudax Bio's address is: 490 Lapp Road, Malvern, PA, United States, 19355 What is Baudax Bio's ISIN number?
Baudax Bio's international securities identification number is: US07160F1075 What is Baudax Bio's CUSIP number?
Baudax Bio's Committee on Uniform Securities Identification Procedures number is: 07160F107
More guides on Finder
Donut savings review
Donut earns up to 10% APY, but you must have an iOS device.
Can Turo’s IPO do better than Uber and Airbnb?
Car-sharing service Turo has filed plans for an IPO. What you need to know.
Monie savings review
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
Covid test stocks
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Is Berkshire Hathaway the next $1 trillion stock?
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Tesla roars into 2022 after December drop
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
How to buy Affinia Therapeutics (AFTX) stock when it goes public
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
How to buy Austin Gold (AUST) stock when it goes public
Everything we know about the Austin Gold IPO, plus information on how to buy in.
How to buy VinFast stock when it goes public
Everything we know about the VinFast IPO, plus information on how to buy in.
NFT-funded LinksDAO moves $10.5 million closer to buying a golf course
Creating a golf club is a thus-far unique application of NFTs, and another step forward for the decentralized economy.
Ask an Expert